Clinical Trial Update: Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) [Phase 2]

View source ↗

Summary

Phase II confirmatory study in erythropoietic protoporphyria completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Clinuvel Pharmaceuticals Limited

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Erythropoietic Protoporphyria | Phase 2 | Status: COMPLETED | Results posted: 2019-09-17